+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

Based on the survey on 1,000 hospitals in 33 countries, European Centre for Disease Prevention and Control (ECDC) estimates that that on any given day, one in 18 patients in a European hospital has healthcare-associated infection (HAIs). Most the countries (26 out of 33) reported the major three types of HAIs: pneumonia and lower respiratory tract infection, surgical site infection and urinary tract infection.

The estimated number of patients in UK acquiring HAIs is approx. 300,000 a year, according to a report by National Institute for Health and Care Excellence (NICE). It costs the NHS approximately £1 billion a year, and £56 million of this is estimated to be incurred after patients are discharged from hospital. NHS has now adopted no-tolerance policy towards spread of HAIs.

After the success of congress held 2016 and 2017, MarketsandMarkets is organizing 3rd Annual Infection Control, Sterilization and Decontamination in Healthcare Congress, scheduled for 21st & 22nd February 2018 in London, UK aiming at providing platform to experts from hospitals, academia, and government institutions discussing the innovations, challenges, and future aspects of infection control, decontamination, and sterilization.

Post Show Report 2017
Click here to view post-show report of the 3rd Annual Infection Control, Sterilization and Decontamination in Healthcare Congress

conference Registration Form



Academic Delegate£495
Public & Private Hospitals£495
Solution Provider Delegate£995


Key highlights

  • Case studies from UK, Ireland, and Germany on successful implementation of policies in hospitals
  • Control of C. difficile infections
  • Case study on Caesarean section surgical site infections
  • Control of water infections and its standards
  • Need of double checking within Sterile Services
  • How to control infections during outbreaks

For more information on the agenda of the conference, you can write to us at amit.shelke@marketsandmarkets.com

Who Should Attend ?

Surgeons, Doctors, Professors, Researchers, and Faculty from Hospitals and academic institutions related to:

  • Infection Control Department
  • Director Infection Prevention and Control
  • Assistant Director Infection Prevention and Control
  • Microbiologist
  • Risk/Governance Manager
  • Junior Doctor
  • Lead Nurse Infection Prevention and Control
  • Senior Lecturer/Lecturer
  • Matron / Nurse
  • Infection Prevention and Control Nurse/Practitioner
  • Consultant Nurses / Specialists

  • Sterile Services Department (SSD) and Decontamination Department
  • Head
  • Manager/ Lead
  • Deputy Manager/Quality Management Representative
  • Coordinator
  • Supervisors
  • Team Leaders
  • Technicians / Engineers

  •  Endoscopy Unit
  • Director
  • Gastroenterologist
  • Head/ Manager
  • Nurse

Advisory Panel

  • Prof. Walid Al-Wali
    Director of Infection Prevention and Control/Consultant Medical Microbiologist
    Clinical Lead of Laboratory Medicine
    The Rotherham NHS Foundation Trust
  • Karen Tweed
    Deputy Operations Director (Decontamination)
    Sheffield Teaching Hospitals NHS Foundation Trust, UK      
  • John Prendergast
    Decontamination Engineer
    Shared Services Partnership/ Specialist Estates Services, Wales, UK


  • Prof. Walid Al-Wali

    Director of Infection Prevention and Control/Consultant Medical Microbiologist Clinical Lead of Laboratory Medicine The Rotherham NHS Foundation Trust
  • Karen Tweed

    Deputy Operations Director (Decontamination) Sheffield Teaching Hospitals NHS Foundation Trust, UK
  • John Prendergast

    Decontamination Engineer Shared Services Partnership/ Specialist Estates Services, Wales, UK
  • Anthony Heard

    Associate Sterile Service Manager Princess Alexandra Hospital NHS Trust, UK
  • Daniel Imoh

    Deputy Decontamination Manager Colchester Hospital University NHS Foundation Trust, UK
  • Moya Alexander

    Decontamination Lead Imperial College Healthcare NHS Trust, UK
  • Dr. Mike Weinbren

    Director Infection Prevention & Control and Consultant Microbiologist Chesterfield Royal Hospital NHS Foundation Trust, UK
  • Dr. Vanda Plecko

    Consultant Microbiologist & Infection Control Doctor NHS Highland, UK
  • Carole Hallam

    Senior Nurse Clinical Governance Calderdale and Huddersfield NHS Foundation Trust, UK
  • Lilian Chiwera

    Infection control surveillance team leader Guys & St Thomas’ NHS Foundation Trust, London, UK
  • Ruth Meinke

    Infection Control Practitioner University Hospital Schleswig-Holstein, Germany
  • Ken Agwuh

    Consultant Clinical Microbiologist & Director for Infection Prevention & Control Doncaster and Bassetlaw NHS Trust, UK
  • Prof. Peter Wilson

    Consultant Microbiology & Virology UCLH NHS Foundation Trust, London, UK
  • Natalie Threapleton

    Senior Infection Prevention Nurse Bradford District Care NHS Foundation Trust, UK
  • Dan Vukelich

    President Association of Medical Device Reprocessors (AMDR), US
  • Caroline Conneely

    Quality Improvement Division, National Decontamination Safety, Ireland




is a biotechnology-based company, that has its research, development and production plant in the city of Alvear, located 20 km from Rosario, Argentina, and was founded in 2006 with national capital. Currently, its Division of Infection Control leads the innovation of products for the control of sterilization, washing, cleaning and thermodisinfection processes for several industries, such as medical, food, veterinary and pharmaceutical.


Clinipak Limited

Clinipak Limited is a leading UK-based company who specialises exclusively in the supply and manufacture of Central Sterile Supplies and Theatre Sterile Supplies. Over the last 30 years, Clinipak has been dedicated to assisting with the cleaning, disinfection and sterilisation of reusable invasive medical devices. In 2017, Key Surgical merged with German-based Interlock and Clinipak Limited to create a leading global provider of sterile processing and O.R. products. The three companies combined offer thousands of products to over 10,000 hospitals and surgical centres around the world.

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  •  15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation/workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-One Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty-minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com


BioPartner is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartnership Programme, members receive extra benefits and support to effectively trade overseas.

At the forefront of the antimicrobial chemotherapy field, the British Society for Antimicrobial Chemotherapy (BSAC) is an inter-professional organisation with over 40 years of experience and achievement in  antibiotic education, research and leadership. Dedicated to saving lives through appropriate use and development of antibiotics now and in the future the  Society communicates effectively about antibiotics and antibiotic usage via workshops, professional guidelines, and initiatives such as Antibiotic Action, UK OPAT Initiative, National Point Prevalence Survey System, Massive Open Online Course (MOOC) on Antimicrobial Stewardship and publication of the Journal of Antimicrobial Chemotherapy (JAC), which with an Impact Factor of 5.439 is among the foremost international journals in antimicrobial research.

The Irish Association of Sterile Services Managers was established in 1989, changed its name to Irish Decontamination Institute in January 2011. Its aim is to ensure its members are up to date with developments in sterile services and to network this information to hospital sterile service departments throughout Ireland. It continues to fulfil this aim by spearheading a revolution in sterilization thought, the organizing of conferences and study days, and the dissemination of information in decontamination and sterilization. Currently, it has representation on the board of the World Forum for Hospital Sterile Supply (WFHSS) and the World Federation and was founding member of the EFHSS.

The IDI has been acknowledged nationally and internationally as a leading organization associated with decontamination and sterilization. Nationally, the IDI continues to promote education in decontamination and sterilization through its involvement with the Institute of Technology, Tallaght course set up in 2000. Internationally, in 2002 the IDI was given the honour of hosting the EFHSS Conference 2002 which was attended by over 300 delegates world wide, and proved to be a great success. Many local and international speakers are now world experts in decontamination and sterilization.

With the advent of new medical device technology and increasing demands from sterile service departments, it is becoming more important that the IDI continues to grow nationally and internationally to meet the ever increasing challenges.

AMDR Association of Medical Device Reprocessors (AMDR)
(AMDR) is the global trade association representing the legal, regulatory and trade interests of the commercial medical device reprocessing industry. AMDR member companies are committed to advancing SUD reprocessing and remanufacturing on all fronts – from maximizing the financial and environmental sustainability benefits to setting the legal and regulatory standard. AMDR member companies provide medical devices that are reprocessed in full compliance with US FDA, European Medical Device Manufacturer or local requiremen

European Society of Clinical Microbiology and Infectious Diseases
ESCMID) is a non-profit organization whose mission is to improve the diagnosis, treatment and prevention of infection-related diseases. This is achieved by promoting and supporting research, education, training, and good medical practice. Since its founding in 1983, ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 33’000 members and affiliated members around the world. ESCMID is registered in Switzerland with offices in Basel. We welcome new colleagues from all nations.

 is the national association representing the medical technology industry in Canada. Our members are committed to providing safe and innovative medical technologies that enhance patient care and advance patient outcomes. The medical technology industry in Canada employs over 35,000 Canadians in close to 1,500 corporate facilities, and has sales of nearly $7 billion per annum. We are committed to ensuring that Canada has a strong and vibrant medical technology industry.

To support 3rd Annual Infection Control, Sterilization and Decontamination in Healthcare Congress please contact amit.shelke@marketsandmarkets.com


3rd Annual Infection Control, Sterilization and Decontamination in Healthcare Congress ? will be held at the Thistle London Heathrow Terminal 5 in London, UK.

Thistle London Heathrow Terminal 5
Bath Road, Longford
London UB7 0EQ 
Hotel:  +44 (0) 800 330 8086 / +44 (0) 20 8624 4010 

Hotel Booking Link

Accommodation is currently available at the Thistle London Heathrow Terminal 5 at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

About the Hotel

Thistle London Heathrow Terminal 5 is the perfect choice if you’re flying early, landing late or just want the holiday to last a little longer. As well as being handy for all the terminals at London Heathrow, we’re located close to the A4 and M25, making Thistle London Heathrow Terminal 5 the ideal base for visits to the nearby Windsor Castle, Kew Gardens and Wembley Stadium.

For further information, please contact:
Email: events@marketsandmarkets.com